Financials

Discussions Technicals Seasonals

AIDA fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

AiDa Pharmaceuticals, Inc. engages in the development, production, and distribution of pharmaceutical products. It offers Etimicin Sulfate, an antibiotic, which treats respiratory infection, kidney and urinogenital infection, soft skin tissue infection, and trauma and operations preventive uses. The company was founded on December 18, 2002 and is headquartered in Hangzhou, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

AIDA does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company